Defence Minister Rajnath Singh on Monday released the first batch of the anti-COVID-19 drug 2-deoxy-D-glucose (2-DG).
Release of 2-deoxy-D-glucose (2-DG) will boost India’s fight against the coronavirus.
Union Health Minister Harsh Vardhan and AIIMS Delhi Director Dr Randeep Guleria were also present during the release of the 2-DG drugs.
Over 10,000 doses of the 2-DG drug, which comes in powder form and is taken orally by dissolving it in water, were launched on Monday.
The drug has been developed by the Defence Research and Development Organisation’s laboratory Institute of Nuclear Medicine and Allied Sciences.
Hyderabad-based Dr Reddy’s Laboratories has been a partner and it is manufacturing the drug for public use.
How the drug works?
The drug is a repurposed drug as the 2-DG molecule is meant for treating tumour, cancer cells. This is a glucose analogue, which looks like glucose but is not.
The virus will take this glucose analogue and will get arrested. The drug will then stop the virus from multiplying.
Director of the Institute of Nuclear Medicine and Allied Sciences, Dr Anil Mishra, has explained i that the oxygen demand increases as the virus is multiplying fast in the body.